For the quarter ending 2025-12-31, SRXH made $2,807K in revenue. -$8,614K in net income. Net profit margin of -306.88%.
| Income Statement | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Net sales | 2,807 | -21,375* | 11,447 | 7,159 |
| Cost of goods sold | 1,753 | -14,198* | 8,028 | 4,776 |
| Gross profit | 1,054 | -7,177* | 3,419 | 2,383 |
| Selling, general and administrative | 4,844 | -2,463 | 18,151 | 3,471 |
| Impairment expense | - | - | 2,690 | - |
| Total operating expenses | 4,844 | -2,463* | 20,841 | 3,471 |
| Gain from continuing operations | -3,790 | -4,714* | -17,422 | -1,088 |
| Interest expense | - | 157* | - | - |
| Interest expense, net | 1,288 | - | - | - |
| Other income | - | - | - | 43 |
| Loss on extinguishment of debt | -3,064 | -179* | - | - |
| Interest income (expense), net | - | - | -975 | 83 |
| Change in fair value of digital assets | -464 | - | - | - |
| Barloss purchase loss | - | 2,890* | 1,693 | - |
| Other expense | 4 | - | - | - |
| Total other income | - | 2,554* | 16 | 126 |
| Total other expense, net | -4,820 | - | - | - |
| Net gain before income taxes | -8,610 | -2,160 | -16,688 | -962 |
| Income tax expense | 4 | - | 138 | 2 |
| Net loss from continuing operations | -8,614 | -2,160* | - | - |
| Deferred tax income (expense) | - | - | -1,693 | - |
| Loss from discontinued operations | - | -2,813* | - | - |
| Net loss | -8,614 | -4,973* | -15,133 | -964 |
| Foreign currency translation adjustment | - | - | -11,791 | - |
| Reclassification of aoci related to discontinued operations | - | -600* | - | - |
| Total comprehensive gain | - | -5,573 | -26,924 | - |
| Basic EPS | -0.26 | -0.264 | -0.74 | -0.37 |
| Diluted EPS | -0.26 | -0.264 | -0.74 | -0.37 |
| Basic Average Shares | 33,737,015 | 21,107,043* | 20,401,138 | 2,605,843 |
| Diluted Average Shares | 33,737,015 | 21,107,043* | 20,401,138 | 2,605,843 |
SRx Health Solutions, Inc. (SRXH)
SRx Health Solutions, Inc. (SRXH)